The possible impact of obesity on androgen, progesterone and estrogen receptors (ERα and ERβ) gene expression in breast cancer patients

Breast Cancer: Basic and Clinical Research

Volumn 5, Issue 1, 2011, Pages

  Jahanban Esfahlan, R ^a,b   Zarghami, N ^a,b   Jahanban Esfahlan, A ^b   Mollazadeh, M ^a,b   Nejati, K ^a,b   Nasiri, M ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Obesity; Steroid hormones; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OBESITY;

EID: 83755229569     PISSN: 11782234     EISSN: None     Source Type: Journal    
DOI: 10.4137/BCBCR.S7707     Document Type: Article

References (35)

1. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A. Vascular effects of adi-ponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond). 2008;114(5):361-74.
2. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221-5.
3. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL et al. Adipocytokines and breast cancer risk. Chin Med J (Engl). 2007;120(18):1592-6.
4. Sellers TA, Kushi LH, Potter JD, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med. 1992;326(20):1323-9.
5. Edman CD, Aiman EJ, Porter JC and MacDonald PC: Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. Am J Obstet Gynecol. 1978;130:439-47.
6. Speirs V, Walker RA. New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast. J Pathol. 2007;211(5): 499-506.
7. Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premeno-pausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1686-91.
8. Cullen R, Maguire TM, McDermott EW, Hill AD, O'Higgins NJ, Duffy MJ. Studies on oestrogen receptor-alpha and -beta mRNA in breast cancer. Eur J Cancer. 2001;37(9):1118-22.
9. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3(5):281-92.
10. Markey GC, Cullen R, Diggin P, Hill AD, Mc Dermott EW, O'Higgins NJ et al. Estrogen receptor-beta mRNA is associated with adverse outcome in patients with breast cancer. Tumour Biol. 2009;30(4):171-5.
11. Skliris GP, Carder PJ, Lansdown MR, Speirs V. Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profling? Br J Cancer. 2001;84(8):1095-8.
12. Zhao C, hlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal. 2008;6:e003.
13. Giuffrida D, Lupo L, La Porta GA, et al. Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer. 1992;28(1): 112-5.
14. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216(1):28-43.
15. Folsom AR, Kaye SA, Prineas RJ, et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol. 1990;131(5):794-803.
16. Verla-Tebit E, Chang-Claude J. Anthropometric factors and the risk of pre-menopausal breast cancer in Germany. Eur J Cancer Prev. 2005;14:419-26.
17. Williams G, Howell A, Jones M. The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer. 1988;58(5):631-4.
18. Carmichael AR, Bendall S, Lockerbie L, Prescott RJ, Bates T. Does obesity compromise survival in women with breast cancer? Breast. 2004;13(2):93-6.
19. Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast. 2004;13(2):85-92.
20. Tough IC, Carter DC, Fraser J, Bruce J. Histological grading in breast cancer. Br J Cancer. 1969;23(2):294-301.
21. WHO. Histological typing of breast tumors. Geneva. 1981. Ref Type: Internet Communication.
22. Thoresen S. Histological grading and clinical stage at presentation in breast carcinoma. Br J Cancer. 1982;46(3):457-8.
23. Maehle BO, Tretli S, Skjaerven R, Thorsen T. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status. Breast Cancer Res Treat. 2001;68(2):159-69.
24. Nomura Y, Tashiro H, Hamada Y, Shigematsu T. Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patients. Breast Cancer Res Treat. 1984;4(1):37-43.
25. Bieche I, Parfait B, Tozlu S, Lidereau R, Vidaud M. Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. Carcinogenesis. 2001;22(9): 1521-6.
26. Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Alvarez AC et al. Androgen receptor expresion in breast cancer: relationship with clini-copathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer. 2008;8:149.
27. Bieche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R. Quanti-fcation of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene. 2001;20(56):8109-15.
28. de CP, Tran-Perennou C, Elie C, Boudou E, Barbaroux C, Poupon MF et al. Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays. Biochem Pharmacol. 2002; 64(3):507-15.
29. Valerie S, Alicia T, Michael J, et al. Coexpression of Estrogen Receptor a and β Poor Prognostic Factors in Human Breast Cancer? Cancer Res. 1999;595:25-528.
30. Knowlden JM, Gee JM, Robertson JF, Ellis IO, Nicholson RI. A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer. Int J Cancer. 2000;89(2):209-12.
31. Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D. Body size and survival in premenopausal breast cancer. Br J Cancer. 1985;51(5):691-7.
32. Abe R, Kumagai N, Kimura M, Hirosaki A, Nakamura T. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med. 1976;120(4): 351-9.
33. Eberlein T, Simon R, Fisher S, Lippman ME. Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat. 1985;5(1):81-6.
34. Pfeiler GH, Buechler C, Neumeier M, et al. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol. Oncol Rep. 2008; 19(3):787-93.
35. Pfaff MW, Lange IG, Daxenberger A, Meyer HH. Tissue-specifc expression pattern of estrogen receptors (ER): quantifcation of ER alpha and ER beta mRNA with real-time RT-PCR. APMIS. 2001;109(5):345-55.